Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
J Natl Cancer Inst. 2011 Feb 16;103(4):E1. doi: 10.1093/jnci/djq531. Epub 2011 Jan 20.
This 12th biannual report of the Cochrane Haematological Malignancies Group highlights recently published randomized controlled trials in the field of hemato-oncology, covering the publication period from September 1, 2009, through June 30, 2010. Implication for clinical practice and methodological aspects are the main principles used to select trials for this report. Studies on tyrosine kinase inhibitors for patients with chronic myeloid leukemia were identified through electronic search of MEDLINE with a broad search filter that covered all topics in hemato-oncology combined with a highly sensitive search filter for randomized studies as described in the Cochrane Handbook for Systematic Reviews of Interventions.
这是 Cochrane 血液恶性肿瘤学组第十二次半年期报告，重点介绍了血液肿瘤学领域近期发表的随机对照试验，涵盖了 2009 年 9 月 1 日至 2010 年 6 月 30 日期间的出版物。对临床实践和方法学方面的影响是选择本报告试验的主要原则。通过电子检索 MEDLINE 并使用广泛的血液肿瘤学主题搜索过滤器，结合干预措施系统评价 Cochrane 手册中描述的用于随机研究的高灵敏度搜索过滤器，发现了针对慢性髓性白血病患者的酪氨酸激酶抑制剂的研究。
